	Cancer risks associated with BRCA1 and BRCA2: Overview and management. Cancer Breen KE, Vashisth S, Liu YL. PMID: 42875977 [PubMed - indexed for MEDLINE]
	When to Operate After Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer: A Critical Review and Multidimensional Decision Framework. J Gastrointest Surg Ho W, Xu W, Zhang J, Guo J. PMID: 42874796 [PubMed - as supplied by publisher]
	Strategies to develop therapeutic cancer vaccines for pancreatic cancer. Lancet Gastroenterol Hepatol Coppi MM, Graciotti M, Digklia A, Kandalaft LE. PMID: 42874623 [PubMed - as supplied by publisher]
	Limited Survival Benefit of Short-Course Neoadjuvant Gemcitabine Plus Nab-Paclitaxel for Resectable Pancreatic Cancer: A Prospective Phase II Study With a Propensity Score-Matched Analysis. J Surg Res Ishido K, Kimura N, Nagase H, Wakasa Y, Wakiya T, Tsuruta S, Miura T, Hakamada K. PMID: 42874369 [PubMed - as supplied by publisher]
	Actinomycetota-Derived Metabolites in Pancreatic Cancer: Chemical Diversity, Metabolic Vulnerability, and Translational Barriers. Curr Oncol Rep Lima DDSP, Silva MDS, Soares MDR, Lima Terceiro LE, de Lima NTR, de Oliveira GD, de Souza TA, Rodrigues-Junior VS, Cibulski SP. PMID: 42873463 [PubMed - indexed for MEDLINE]
	From Nature to Medicine: Overcoming the Limitations of Herbal Therapeutics for Pancreatic Cancer Treatment Based on Nanotechnology. Nanomaterials (Basel) Muteeb G, Basem Y, Kotb AA, Magdy NT, Alghuwainem GY, Aatif M, Farhan M, Khafaga DSR. PMID: 42873039 [PubMed]
	Editorial for PREOPANC-2, a multicenter, open-label, phase 3 randomized trial comparing neoadjuvant FOLFIRINOX vs. neoadjuvant gemcitabine based chemoradiotherapy in resectable and borderline resectable pancreatic cancer. Hepatobiliary Surg Nutr Li C, Lim KH. PMID: 42871417 [PubMed]
	Development and temporal validation of nomograms and machine learning models for predicting overall and cancer-specific survival in primary distal cholangiocarcinoma: a SEER-based study. Transl Cancer Res Shang W, Duan X. PMID: 42870853 [PubMed]
	Identification of hepatitis B virus-associated membrane proteins as prognostic biomarkers for hepatocellular carcinoma based on retrospective analysis of integrated membrane proteomics. Transl Cancer Res Liu Z, Wan J, Deng G, Zhang M, Zhang S, Liu Q, Ouyang L, Liu S. PMID: 42870789 [PubMed]
	IHPBA 2026 global guideline for the management of hepatocellular carcinoma in resource-constrained healthcare settings. HPB (Oxford) Siriwardena AK, Jonas E, Bonney G, Iyer S, Primrose J, Filobbos R, Lakhey P, Kingham TP, Siriwardhane M, Dixon E, Gimenez ME, Jeyarajah R, Ramia JM, Lendoire J, Song TQ, Lancellotti F, Kruger D, Harrison EM, Abellay G, Imventarza O, Prince MI, Shrikhande SV, Bhandari R, Dharmapala A, Siriwardana R, Martinez IC, Barker S, Finch LM, Stattner S, Gulla AK, Kerem M, Buis CI, Balakrishnan A, Wigmore SJ, Leggett D, Comibra F, de Wilde R, Serrablo A, Supe A, Bayramov N, Adair A, Berrevoet F, Maglione M, Jarnagin W, Kokudo N, Madhavan K, Smith M, Adam R, IHPBA Legacy Committee, IHPBA Research committee and IHPBA HCC global guideline group. PMID: 42869716 [PubMed - as supplied by publisher]
	Pancreatic Adenocarcinoma, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw Ko AH, Malafa MP, Aguilera T, Basturk O, Benson AB 3rd, Cardin DB, Chiorean EG, Christensen JA, Chung V, Czito B, Chiaro MD, Dillhoff M, Donahue TR, Fountzilas C, Hardacre J, Klute K, Kunstman JW, Lim KH, LoConte N, Lowy AM, Masood A, Moravek C, Nakakura EK, Narang AK, Nardo L, Obando J, Polanco PM, Poultsides G, Reddy S, Reyngold M, Scaife C, Shergill A, Singh H, Truty MJ, Vollmer C Jr, Weinberg D, Wolff RA, Wolpin BM, McCullough B, Roth SL, Ramakrishnan S. PMID: 42869082 [PubMed - indexed for MEDLINE]
	Value of tumor burden score combined with alpha-fetoprotein stratification in transarterial chemoembolization plus tyrosine kinase inhibitors and immune checkpoint inhibitors as triple conversion therapy for patients with initially unresectable hepatocellular carcinoma: a multicenter retrospective study (GUIDANCE010). Eur J Surg Oncol Li ZC, Li CH, Yang DL, Su JY, Liu SP, Ye L, Peng N, Zeng FJ, Li MJ, Liang YR, Chen SC, Yang FQ, Wang XY, Qin C, Zhong TM, Mao XS, Su Z, Dong XF, Yang J, Xu B, Su H, Han RX, Qin ZL, Mo BY, Huang HG, Zhong JH, GUIDANCE investigators. PMID: 42868946 [PubMed - as supplied by publisher]
	Toward Clinically Actionable Prediction of Recurrence and Metastatic Progression in Pancreatic Ductal Adenocarcinoma: A Systematic Review. JCO Clin Cancer Inform Gong L, Chang C, Agyekum A, Aswani N, Yang JY, Shahinnian P, Manji G, Kang SK, Hur C. PMID: 42868319 [PubMed - indexed for MEDLINE]
	MRI for restaging pancreatic cancer. Insights Imaging Zamboni GA, Omboni F, Panozzo I. PMID: 42867719 [PubMed]
	Cumulative obesity exposure and hepato-pancreato-biliary cancer risk following different weight-loss interventions: retrospective cohort study. Ann Med Surg (Lond) Kukeev I, Arnon Y, Quint E, Freih SA, Osyntsov A, Dukhno O. PMID: 42866765 [PubMed]
	Pancreatic Tuberculosis Mimicking Pancreatic Cancer in a Young Immunocompetent Man: A Case Report and Literature Review. Int Med Case Rep J Kazemi K, Soleimani N, Jafari M, Pouraminaee F, Dehghani Z, Mohammadzadeh S, Dehbanizadeh S. PMID: 42866548 [PubMed - indexed for MEDLINE]
	Peri-interventional neutrophil extracellular traps and immune surveillance in hepatocellular carcinoma: mechanisms, biomarkers, and recurrence after liver resection or thermal ablation. Front Oncol Xu H, Yi J, Zhang W, Zhu S, Liu Z. PMID: 42865793 [PubMed]
	Efficacy and toxicities of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel as first-line chemotherapy for unresectable pancreatic cancer: a systematic review and meta-analysis. Front Oncol Hu C, Zhan L, Li Y, Ren X, Yu Z. PMID: 42865438 [PubMed]
	Recent advances in systemic therapy for biliary tract cancer: Evidence from Japan and recommendations in guidelines. Proc Jpn Acad Ser B Phys Biol Sci Okusaka T, Furuse J, Konishi M, Ohtsuka M. PMID: 42864016 [PubMed - indexed for MEDLINE]
	Novel Tool to Predict Primary Tumor Location in the Setting of Metastatic Cancer With Unknown Primary. JCO Oncol Pract Eldeeb K, Badat S, Perlow HK, Baydoun A, Vempati P, Yang Y, Spratt DE, Wang M, Zaorsky NG. PMID: 42863101 [PubMed - as supplied by publisher]

Articles 1 - 20 / 61845

Page 1 of 3093



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy